Main > ONCOLOGY (**) > Lung>NSCLC>Non-Squamous>MET EGFR->+ > TREAT.: > Co: USA. G. AtezolizuMAb Inj.

---

Co: USA. G. AtezolizuMAb Inj.'s subsections
(*) USA OK Date: 2018. 12.05. (1)
(*) USA OK Date: 2019. 12.03. (2)
+Abraxane ® + CarboPlatin (2)
+BevacizuMAb+Paclitaxel+Carbo (1)
>or ALK-
Company
Patent>Assignee; Claims; No.; Etc.
TradeMark
TradeMark Web-Site

Co: USA. G. AtezolizuMAb Inj.'s products
This section has no products